We keep your e-prescribing connected and your pharmacy routing accurate for semaglutide, tirzepatide, and related protocols. Because FDA policy on compounded GLP-1s has tightened as the shortages were declared resolved, we build workflows that can adapt when you change pharmacies or move between compounded and branded products. That includes updating protocol templates, consent documentation, and audit trails so nothing breaks clinically or from a compliance standpoint. We coordinate with your EHR and pharmacy partners so refills and renewals flow smoothly. The goal is uninterrupted patient care even as the regulatory landscape shifts.